Literature DB >> 328397

Diarrhea caused by Escherichia coli that produce only heat-stable enterotoxin.

M M Levine, E S Caplan, D Waterman, R A Cash, R B Hornick, M J Snyder.   

Abstract

To determine the role of Escherichia coli heat-stable enterotoxin (ST) as a virulence factor in human diarrhea, a strain that elaborates only ST (E. coli 214-4) was fed to free-living volunteers in doses of 10(6), 10(8), and 10(10) organisms. Short-lived (1 day) mild illness consisting of abdominal cramps with vomiting or diarrhea occurred in three of five individuals fed 10(8). Typical travelers' diarrhea (loose stools, abdominal cramps, and low-grade fever for 2 to 3 days) was seen in four of five volunteers given 10(10); two had brief cholera-like purging of rice-water stools. Despite fever, there was no evidence of mucosal invasion. E. coli 214-4 became the predominant coliform in stools; coproculture isolates were uniformly negative for heat-labile enterotoxin (LT), whereas most produced ST. Ten of 13 individuals developed rises in antibody to somatic E. coli antigen, and none had rises in LT antitoxin. E. coli that elaborate only ST can cause diarrheal disease in adults.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 328397      PMCID: PMC421084          DOI: 10.1128/iai.17.1.78-82.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  A SIMPLIFIED GASTROINTESTINAL BIOPSY CAPSULE.

Authors:  J B CAREY
Journal:  Gastroenterology       Date:  1964-05       Impact factor: 22.682

2.  Fecal leukocytes in diarrheal illness.

Authors:  J C Harris; H L Dupont; R B Hornick
Journal:  Ann Intern Med       Date:  1972-05       Impact factor: 25.391

3.  Cholera-like toxic effect of culture filtrates of Escherichia coli.

Authors:  D R Nalin; A K Bhattacharjee; S H Richardson
Journal:  J Infect Dis       Date:  1974-12       Impact factor: 5.226

4.  Pathogenesis of Shigella dysenteriae 1 (Shiga) dysentery.

Authors:  M M Levine; H L DuPont; S B Formal; R B Hornick; A Takeuchi; E J Gangarosa; M J Snyder; J P Libonati
Journal:  J Infect Dis       Date:  1973-03       Impact factor: 5.226

5.  Enterotoxigenic Escherichia coli and Reovirus-like agent in rural Bangladesh.

Authors:  R W Ryder; D A Sack; A Z Kapikian; J C McLaughlin; J Chakraborty; A S Mizanur Rahman; M H Merson; J G Wells
Journal:  Lancet       Date:  1976-03-27       Impact factor: 79.321

6.  Travelers' diarrhea in Mexico. A prospective study of physicians and family members attending a congress.

Authors:  M H Merson; G K Morris; D A Sack; J G Wells; J C Feeley; R B Sack; W B Creech; A Z Kapikian; E J Gangarosa
Journal:  N Engl J Med       Date:  1976-06-10       Impact factor: 91.245

7.  Enterotoxigenic Escherichia coli and idiopathic diarrhoea in Bangladesh.

Authors:  D R Nalin; J C McLaughlin; M Rahaman; M Yunus; G Curlin
Journal:  Lancet       Date:  1975-12-06       Impact factor: 79.321

8.  Enterotoxin testing of Escherichia coli causing epidemic infantile enteritis in the U.K.

Authors:  R J Gross; S M Scotland; B Rowe
Journal:  Lancet       Date:  1976-03-20       Impact factor: 79.321

9.  Differences in the response of rabbit small intestine to heat-labile and heat-stable enterotoxins of Escherichia coli.

Authors:  D G Evans; D J Evans; N F Pierce
Journal:  Infect Immun       Date:  1973-06       Impact factor: 3.441

10.  Cholera toxoid boosts serum Escherichia coli antitoxin in humans.

Authors:  D R Nalin; A al-Mahmud; G Curlin; A Ahmed; J Peterson
Journal:  Infect Immun       Date:  1974-10       Impact factor: 3.441

View more
  54 in total

1.  Heat-stable enterotoxin from Escherichia coli: factors involved in growth and toxin production.

Authors:  W M Johnson; H Lior; K G Johnson
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

2.  Molecular homogeneity of heat-stable enterotoxins produced by bovine enterotoxigenic Escherichia coli.

Authors:  A M Saeed; N S Magnuson; N Sriranganathan; D Burger; W Cosand
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

3.  Serotypes of attachment pili of enterotoxigenic Escherichia coli isolated from humans.

Authors:  C F Deneke; G M Thorne; S L Gorbach
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

4.  Protective effect of active immunization with purified Escherichia coli heat-labile enterotoxin in rats.

Authors:  F A Klipstein; R F Engert
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

5.  Hemagglutination and adhesiveness of toxigenic Escherichia coli isolated from humans.

Authors:  G M Thorne; C F Deneke; S L Gorbach
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

6.  Increased Escherichia coli enterotoxin detection after concentrating culture supernatants: possible new enterotoxin detectable in dogs but not in infant mice.

Authors:  D R Nalin; M M Levine; C R Young; E J Bergquist; J C McLaughlin
Journal:  J Clin Microbiol       Date:  1978-12       Impact factor: 5.948

7.  Immunity to enterotoxigenic Escherichia coli.

Authors:  M M Levine; D R Nalin; D L Hoover; E J Bergquist; R B Hornick; C R Young
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

8.  Characterization of heat-stable enterotoxin from a hypertoxigenic Escherichia coli strain that is pathogenic for cattle.

Authors:  A M Saeed; N S Magnuson; C C Gay; R N Greenberg
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

9.  Enterotoxin-producing bacteria stools from Swedish United Nations soldiers in Cyprus.

Authors:  E Bäck; M Jonsson; T Wadström
Journal:  Infection       Date:  1978       Impact factor: 3.553

10.  The pangenome structure of Escherichia coli: comparative genomic analysis of E. coli commensal and pathogenic isolates.

Authors:  David A Rasko; M J Rosovitz; Garry S A Myers; Emmanuel F Mongodin; W Florian Fricke; Pawel Gajer; Jonathan Crabtree; Mohammed Sebaihia; Nicholas R Thomson; Roy Chaudhuri; Ian R Henderson; Vanessa Sperandio; Jacques Ravel
Journal:  J Bacteriol       Date:  2008-08-01       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.